Fallon, NY
James Fallon, Armonk, NY US
Patent application number | Description | Published |
---|---|---|
20130202581 | ENZYME COMPOSITIONS AND USE THEREOF FOR WOUND HEALING - Compositions and methods of using the compositions for wound healing are provided. The compositions include one or more digestive enzymes, for example, one or more protease, lipases, and amylases. The compositions can be formulated as topical pharmaceutical compositions and can be used for faster healing through stimulation of epidermal cells in the absence of scarring. The compositions may deposit a short term fibrosis and help prevent re-opening of wounds. The compositions may improve recruitment of white blood cells, thereby inducing or enhancing growth factor and immune system activation via an enzyme antibiotic effect. The compositions may enhance the epidermal integrity beyond that of the normal physiological restorative process. Application of the compositions may result in greater re-growth of hair on regions of wounds healed with enzyme and reduced alopecia. The compositions may be administered without causing allergic reactions and without causing biological damage or burns. | 08-08-2013 |
20130241726 | SYSTEM AND METHOD FOR EMERGENCY NOTIFICATION CONTENT DELIVERY - A method for disseminating emergency notification content from an emergency originating source. The method comprising: delivering the emergency notification content from the emergency originating source to at least one transmitting party; selecting a subset of users from among a set of users for dissemination of the emergency notification content based on the subject matter of the emergency notification content; and delivering the emergency notification content from the at least one transmitting party to a device corresponding to each user from the selected subset of users. | 09-19-2013 |
20140127184 | COMPOUNDS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS - Described herein are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of a neuropsychiatric disorder. Also described herein is a method for treating an individual with a neuropsychiatric disorder using digestive enzymes and their derivatives to alleviate the symptoms of neuropsychiatric disorders. The method comprises administering to the individual an effective amount of digestive enzymes that are either naturally or recombinantly derived, or their derivatives, in an amount effective to reduce one or more symptoms of the neuropsychiatric disorder. | 05-08-2014 |
20140147500 | Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery Systems - Pharmaceutical compositions comprising one or more digestive enzymes and one or more gastrointestinal modulators of acid are provided. The one or more digestive enzymes may be coated, e.g., with a lipid. Also disclosed are methods for their use and controlled delivery in treating individuals with neurological, behavioral, infectious, or genetic diseases or conditions susceptible to treatment with digestive enzymes. | 05-29-2014 |
James Fallon, Rochester, NY US
Patent application number | Description | Published |
---|---|---|
20080218570 | IMAGING ON FLEXIBLE PACKAGING SUBSTRATES - Methods and devices for forming, such as by printing, high quality, high throughput, ultraviolet curable gel ink images on flexible substrates for packaging applications are disclosed. The methods and devices have excellent image quality and do not require pinning of the ink during color printing or nitrogen inerting during curing. | 09-11-2008 |
James John Fallon, Armonk, NY US
Patent application number | Description | Published |
---|---|---|
20080309913 | SYSTEMS AND METHODS FOR LASER RADAR IMAGING FOR THE BLIND AND VISUALLY IMPAIRED - A 3D imaging ladar system comprises a solid state laser and geiger-mode avalanche photodiodes utilizing a scanning imaging system in conjunction with a user interface to provide 3D spatial object information for vision augmentation for the blind. Depth and located object information is presented acoustically by: 1) generating an audio acoustic field to present depth as amplitude and the audio image as a 2D location. 2) holographic acoustical imaging for a 3D sweep of the acoustic field. 3) a 2D acoustic sweep combined with acoustic frequency information to create a 3D presentation. | 12-18-2008 |
Joan Fallon, New Rochelle, NY US
Patent application number | Description | Published |
---|---|---|
20100260857 | Enzyme delivery systems and methods of preparation and use - This invention relates to coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations. This invention further relates to methods of preparation and use of the systems, pharmaceutical compositions and preparations to treat persons having ADD, ADHD, autism, cystic fibrosis and other behavioral and neurological disorders. | 10-14-2010 |
Joan Fallon, Bronxville, NY US
Patent application number | Description | Published |
---|---|---|
20140127184 | COMPOUNDS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS - Described herein are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of a neuropsychiatric disorder. Also described herein is a method for treating an individual with a neuropsychiatric disorder using digestive enzymes and their derivatives to alleviate the symptoms of neuropsychiatric disorders. The method comprises administering to the individual an effective amount of digestive enzymes that are either naturally or recombinantly derived, or their derivatives, in an amount effective to reduce one or more symptoms of the neuropsychiatric disorder. | 05-08-2014 |
Joan M. Fallon, Yonkers, NY US
Patent application number | Description | Published |
---|---|---|
20080219966 | METHODS OF TREATING PERVASIVE DEVELOPMENT DISORDERS - A therapeutic method for treating an individual diagnosed with PDD pervasive developmental disorder comprises determining the efficacy of digestive enzyme administration for the treatment of the individual based on a measure of the individual's chymotrypsin level, and administering digestive enzymes to the individual based on the determination of the measure of the individual's chymotrypsin level. A method for reducing the amount of methylphenidate (Ritalin) being taken by an individual with attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) by administering a therapeutic amount of digestive enzymes is also provided. | 09-11-2008 |
20090197289 | METHOD FOR CONFIRMING A DIAGNOSIS OF AUTISM - A method for confirming a diagnosis of autism in of an individual comprises obtaining a sample of feces from an individual, determining a quantitative level of chymotrypsin present in the sample, and comparing the quantitative level of fecal chymotrypsin in the stool sample of the person having autism to a stool sample from an individual that has a normal fecal chymotrypsin level and does not have autism and confirming a diagnosis of autism based on the measurement of the quantitative level of fecal chymoptrypsin. | 08-06-2009 |
20090232789 | NOVEL PHARMACEUTICAL PREPARATION FOR PREECLAMPSIA, ECLAMPSIA, AND TOXEMIA, AND THEIR RELATED SYMPTOMS AND RELATED DISORDERS OF PREGNANCY - A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and the method for preparing the therapeutic agents is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the maternal GI tract to determine the likelihood of developing preeclampsia, pregnancy induced hypertension, and eclampsia/toxemia is disclosed. | 09-17-2009 |
Joan M. Fallon, New Rochelle, NY US
Patent application number | Description | Published |
---|---|---|
20090130081 | Method for treating pervasive development disorders - A method of utilizing the chymotrypsin level of an individual as a measure of the success of secretin, other neuropeptides, and peptides or digestive enzyme administration to such individuals, and in particular, as a prognosticative of potential secretin, other neuropeptides, peptides, and digestive enzyme administration for persons having ADD, ADHD, Autism and other PDD related disorders. In one aspect, a method for determining the efficacy of secretin, other neuropeptides, peptides, or digestive enzymes for the treatment of an individual diagnosed with a pervasive developmental disorder (PDD) comprises obtaining a sample of feces from an individual, determining a quantitative level of chymotrypsin present in the sample, and correlating the quantitative level of chymotrypsin determined to be present in the sample with the PDD to determine the efficacy of treating the individual with secretin, other neuropeptides, peptides, or digestive enzyme administration. In another aspect, a therapeutic method for treating an individual diagnosed with a PDD pervasive developmental disorder comprises determining the efficacy of secretin, other neuropeptides, peptides, and digestive enzyme administration for the treatment of the individual based on a measure of the individual's chymotrypsin level, and administering secretin, other neuropeptides, peptides, or digestive enzymes to the individual based on the determination of the measure of the individual's chymotrypsin level. | 05-21-2009 |
Raymond Fallon, Poughkeepsie, NY US
Patent application number | Description | Published |
---|---|---|
20100004970 | METHOD AND STRUCTURE FOR IMPLEMENTING B2B TRADING PARTNER BOARDING - A computerized method (and structure) of implementing a business-to-business (B2B) boarding process includes providing a set of questions related to the B2B boarding process to a new business to be boarded into an existing B2B system. | 01-07-2010 |
Thomas M. Fallon, East Aurora, NY US
Patent application number | Description | Published |
---|---|---|
20100000914 | Method and apparatuses for screening - A method and apparatus are disclosed for screening materials. A vibratory screening machine includes a first frame and a second frame. The second frame is attached to the first frame by elastomeric mountings. A vibratory motor is configured to vibrate the first frame and the second frame. An attachment arrangement is configured to secure a replaceable screen assembly to the first frame. The replaceable screen assembly is in contact with the second frame such that the second frame excites the replaceable screen assembly. | 01-07-2010 |